• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非酒精性脂肪性肝病分层的肝酶与死亡率之间的关系:NHANES III 分析。

The Association between Liver Enzymes and Mortality Stratified by Non-Alcoholic Fatty Liver Disease: An Analysis of NHANES III.

机构信息

Medical Faculty, University of Zurich, Pestalozzistrasse 3, CH-8032 Zurich, Switzerland.

Division of Chronic Disease Epidemiology, Epidemiology, Biostatistics and Prevention Institute (EBPI), University of Zurich, Hirschengraben 84, CH-8001 Zurich, Switzerland.

出版信息

Nutrients. 2023 Jul 7;15(13):3063. doi: 10.3390/nu15133063.

DOI:10.3390/nu15133063
PMID:37447388
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10346959/
Abstract

Associations between liver enzymes or De Ritis ratio (DRR; aspartate aminotransferase (AST)/alanine aminotransferase (ALT)) and mortality stratified by non-alcoholic fatty liver disease (NAFLD), which have rarely been analyzed in previous studies, were investigated using the National Health and Nutrition Examination Survey (NHANES) III (1988-1994). Participants without risk factors for liver diseases other than NAFLD were linked with National Death Index records through 2019 ( = 11,385) and divided into two cohorts with or without NAFLD, based on ultrasound examination. Liver enzyme concentrations were categorized into sex-specific deciles and subsequently grouped (AST and ALT: 1-3, 4-9, 10; gamma glutamyltransferase (GGT): 1-8, 9-10). DRR was categorized into tertiles. Cox proportional hazards regression models adjusted for confounders were fitted to estimate associations with mortality. Compared with low levels, high GGT and DRR in participants with and without NAFLD had significantly higher hazard ratios for all-cause mortality. Compared with intermediate concentrations, low ALT showed higher all-cause mortality in participants with and without NAFLD, whereas low AST had higher HR in participants without NAFLD and high AST in those with NAFLD. Mortality was associated with liver enzymes or DRR in participants both with and without NAFLD, indicating that the relationship is not mediated solely by hepatocellular damage.

摘要

使用 1988-1994 年国家健康和营养调查(NHANES III)研究了以前的研究很少分析的非酒精性脂肪性肝病(NAFLD)分层的肝酶或 De Ritis 比值(DRR;天冬氨酸氨基转移酶(AST)/丙氨酸氨基转移酶(ALT))与死亡率之间的关联。无除 NAFLD 以外的肝病危险因素的参与者通过国家死亡指数记录与 2019 年(=11385)相关联,并根据超声检查分为有或没有 NAFLD 的两个队列。肝酶浓度分为性别特异性十分位数,然后根据 AST 和 ALT(1-3、4-9、10;γ-谷氨酰转移酶(GGT)(1-8、9-10)进行分组。DRR 分为三分位。拟合 Cox 比例风险回归模型以调整混杂因素,以估计与死亡率的关联。与低水平相比,有和没有 NAFLD 的参与者中高水平的 GGT 和 DRR 与全因死亡率的风险比显著更高。与中间浓度相比,有和没有 NAFLD 的参与者中低 ALT 显示出更高的全因死亡率,而没有 NAFLD 的参与者中低 AST 具有更高的 HR,有 NAFLD 的参与者中高 AST 具有更高的 HR。NAFLD 有和没有 NAFLD 的参与者的肝酶或 DRR 与死亡率相关,表明这种关系不仅仅是由肝细胞损伤介导的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a34/10346959/858048aa152c/nutrients-15-03063-g002a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a34/10346959/f36a599e43e6/nutrients-15-03063-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a34/10346959/858048aa152c/nutrients-15-03063-g002a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a34/10346959/f36a599e43e6/nutrients-15-03063-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a34/10346959/858048aa152c/nutrients-15-03063-g002a.jpg

相似文献

1
The Association between Liver Enzymes and Mortality Stratified by Non-Alcoholic Fatty Liver Disease: An Analysis of NHANES III.非酒精性脂肪性肝病分层的肝酶与死亡率之间的关系:NHANES III 分析。
Nutrients. 2023 Jul 7;15(13):3063. doi: 10.3390/nu15133063.
2
Noninvasive fatty liver markers predict liver disease mortality in the U.S. population.非侵入性脂肪肝标志物可预测美国人群的肝病死亡率。
Hepatology. 2016 Apr;63(4):1170-83. doi: 10.1002/hep.28390. Epub 2016 Jan 22.
3
Association of the serum transaminase with mortality among the US elderly population.美国老年人群血清转氨酶与死亡率的关联。
J Gastroenterol Hepatol. 2022 May;37(5):946-953. doi: 10.1111/jgh.15815. Epub 2022 Mar 17.
4
Elevated ALT/AST ratio as a marker for NAFLD risk and severity: insights from a cross-sectional analysis in the United States.ALT/AST 比值升高作为非酒精性脂肪性肝病风险和严重程度的标志物:来自美国横断面分析的见解。
Front Endocrinol (Lausanne). 2024 Aug 26;15:1457598. doi: 10.3389/fendo.2024.1457598. eCollection 2024.
5
Association between the alanine aminotransferase/aspartate aminotransferase ratio and new-onset non-alcoholic fatty liver disease in a nonobese Chinese population: a population-based longitudinal study.非肥胖中国人群中丙氨酸氨基转移酶/天冬氨酸氨基转移酶比值与新发非酒精性脂肪性肝病的关系:一项基于人群的纵向研究。
Lipids Health Dis. 2020 Nov 25;19(1):245. doi: 10.1186/s12944-020-01419-z.
6
In patients with non-alcoholic fatty liver disease, metabolically abnormal individuals are at a higher risk for mortality while metabolically normal individuals are not.在非酒精性脂肪性肝病患者中,代谢异常个体的死亡率更高,而代谢正常个体则没有。
Metabolism. 2013 Mar;62(3):352-60. doi: 10.1016/j.metabol.2012.08.005. Epub 2012 Sep 19.
7
Associations of serum liver enzyme levels and their changes over time with all-cause and cause-specific mortality in the general population: a large-scale national health screening cohort study.血清肝酶水平及其随时间变化与普通人群全因和死因特异性死亡率的关系:一项大规模的全国性健康筛查队列研究。
BMJ Open. 2019 Jun 1;9(5):e026965. doi: 10.1136/bmjopen-2018-026965.
8
Prevalence and predictors of elevated liver enzyme levels in Mexico: The Mexican National Health and Nutrition Survey, 2016.墨西哥肝酶水平升高的患病率及预测因素:2016年墨西哥国家健康与营养调查
Ann Hepatol. 2021 Dec;26:100562. doi: 10.1016/j.aohep.2021.100562. Epub 2021 Oct 13.
9
Gender perspective on the association between liver enzyme markers and non-alcoholic fatty liver disease: insights from the general population.性别视角下肝酶标志物与非酒精性脂肪性肝病的关联:来自一般人群的见解。
Front Endocrinol (Lausanne). 2023 Dec 6;14:1302322. doi: 10.3389/fendo.2023.1302322. eCollection 2023.
10
The association of liver enzymes with biomarkers of subclinical myocardial damage and structural heart disease.肝脏酶与亚临床心肌损伤及结构性心脏病生物标志物的关联。
J Hepatol. 2015 Apr;62(4):841-7. doi: 10.1016/j.jhep.2014.11.024. Epub 2014 Nov 27.

引用本文的文献

1
Metabolic and hepatic biomarkers associated with MASLD in the Chinese population.中国人群中与代谢相关脂肪性肝病(MASLD)相关的代谢和肝脏生物标志物。
Sci Rep. 2025 Aug 27;15(1):31593. doi: 10.1038/s41598-025-17219-3.
2
Developing and validating a predictive model for all-cause mortality in patients with metabolic dysfunction-associated steatotic liver disease.开发并验证代谢功能障碍相关脂肪性肝病患者全因死亡率的预测模型。
Diabetol Metab Syndr. 2025 May 20;17(1):161. doi: 10.1186/s13098-025-01724-6.
3
Genotype-by-Environment Interactions in Nonalcoholic Fatty Liver Disease and Chronic Illness among Mexican Americans: The Role of Acculturation Stress.

本文引用的文献

1
Updated S2k Clinical Practice Guideline on Non-alcoholic Fatty Liver Disease (NAFLD) issued by the German Society of Gastroenterology, Digestive and Metabolic Diseases (DGVS) - April 2022 - AWMF Registration No.: 021-025.德国胃肠病学、消化与代谢疾病学会(DGVS)发布的《非酒精性脂肪性肝病(NAFLD)S2k临床实践指南更新版》——2022年4月——德国医学科学与医学技术评估委员会注册编号:021 - 025
Z Gastroenterol. 2022 Sep;60(9):e733-e801. doi: 10.1055/a-1880-2388. Epub 2022 Sep 13.
2
Association between alanine aminotransferase and all-cause mortality rate: Findings from a study on Japanese community-dwelling individuals.丙氨酸氨基转移酶与全因死亡率的关系:来自日本社区居民研究的结果。
J Clin Lab Anal. 2022 May;36(5):e24445. doi: 10.1002/jcla.24445. Epub 2022 Apr 18.
3
非酒精性脂肪性肝病和墨西哥裔美国人慢性疾病中的基因型-环境互作:文化适应压力的作用。
Genes (Basel). 2024 Aug 1;15(8):1006. doi: 10.3390/genes15081006.
4
Gene-by-Environment Interaction in Non-Alcoholic Fatty Liver Disease and Depression: The Role of Hepatic Transaminases.非酒精性脂肪性肝病与抑郁症中的基因-环境相互作用:肝转氨酶的作用
Med Res Arch. 2023 Sep;11(9). doi: 10.18103/mra.v11i9.4408. Epub 2023 Sep 28.
Association of the serum transaminase with mortality among the US elderly population.美国老年人群血清转氨酶与死亡率的关联。
J Gastroenterol Hepatol. 2022 May;37(5):946-953. doi: 10.1111/jgh.15815. Epub 2022 Mar 17.
4
A Unifying Approach for GFR Estimation: Recommendations of the NKF-ASN Task Force on Reassessing the Inclusion of Race in Diagnosing Kidney Disease.一种统一的肾小球滤过率估计方法:NKF-ASN 工作组关于重新评估种族在诊断肾脏疾病中的纳入的建议。
Am J Kidney Dis. 2022 Feb;79(2):268-288.e1. doi: 10.1053/j.ajkd.2021.08.003. Epub 2021 Sep 23.
5
New Creatinine- and Cystatin C-Based Equations to Estimate GFR without Race.新型基于肌酐和胱抑素 C 的估算肾小球滤过率方程,无需考虑种族因素。
N Engl J Med. 2021 Nov 4;385(19):1737-1749. doi: 10.1056/NEJMoa2102953. Epub 2021 Sep 23.
6
Combined evaluation of aminotransferases improves risk stratification for overall and cause-specific mortality in older patients.联合评估氨基转移酶可改善老年患者的全因和死因特异性死亡率的风险分层。
Aging Clin Exp Res. 2021 Dec;33(12):3321-3331. doi: 10.1007/s40520-021-01979-9. Epub 2021 Sep 10.
7
Aspartate aminotransferase to alanine aminotransferase ratio is associated with frailty and mortality in older patients with heart failure.天门冬氨酸氨基转移酶与丙氨酸氨基转移酶比值与老年心力衰竭患者的虚弱和死亡率相关。
Sci Rep. 2021 Jun 7;11(1):11957. doi: 10.1038/s41598-021-91368-z.
8
Non-alcoholic fatty liver disease.非酒精性脂肪性肝病。
Lancet. 2021 Jun 5;397(10290):2212-2224. doi: 10.1016/S0140-6736(20)32511-3. Epub 2021 Apr 21.
9
2. Classification and Diagnosis of Diabetes: .2. 糖尿病的分类和诊断: 。
Diabetes Care. 2021 Jan;44(Suppl 1):S15-S33. doi: 10.2337/dc21-S002.
10
The association of sex steroid hormone concentrations with non-alcoholic fatty liver disease and liver enzymes in US men.美国男性性激素浓度与非酒精性脂肪性肝病和肝酶的关系。
Liver Int. 2021 Feb;41(2):300-310. doi: 10.1111/liv.14652.